Dr. Jennifer McVean, MD, stands at the forefront of pediatric diabetes care, blending her personal journey with Type 1 Diabetes and her extensive medical expertise to transform treatment approaches for children and families worldwide.
Diagnosed with Type 1 Diabetes at the age of 11, Dr. McVean’s firsthand experience has profoundly influenced her compassionate approach to patient care. She earned her medical degree from the University of Minnesota Medical School, completed her pediatric residency at the University of Colorado, and pursued a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. Board-certified in both Pediatrics and Pediatric Endocrinology, she has dedicated nearly two decades to advancing pediatric diabetes management through clinical practice, research, and medical innovation.
Currently serving as Senior Director of Medical Affairs for Medtronic Diabetes, Dr. McVean has been instrumental in the development and implementation of automated insulin delivery systems. Her research has demonstrated that these systems can significantly improve glycemic control and reduce the burden of diabetes management, particularly during overnight periods. A study published in Diabetes, Obesity and Metabolism highlighted the benefits of the MiniMed™ 780G system in enhancing sleep quality and glycemic outcomes for pediatric patients.
Beyond her clinical and research contributions, Dr. McVean is deeply involved in diabetes advocacy and education. She has collaborated with organizations such as the Juvenile Diabetes Research Foundation (JDRF) and the American Diabetes Association (ADA), and has served as a staff physician at ADA’s Camp Needlepoint, providing support and education to children living with diabetes.
Dr. McVean’s commitment extends to mentoring and community outreach, focusing on improving diabetes awareness, prevention, and treatment. Her leadership continues to influence the future of diabetes care, aiming to help individuals achieve healthier, more independent lives while advancing innovations that reduce the burden of disease for future generations.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
For more information about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.